103 related articles for article (PubMed ID: 38766009)
1. Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx.
Gai D; Caviness PC; Lazarenko OP; Chen JF; Randolph CE; Zhang Z; Cheng Y; Sun F; Xu H; Blackburn ML; Tricot G; Shaughnessy JD; Chen JR; Zhan F
Res Sq; 2024 May; ():. PubMed ID: 38766009
[TBL] [Abstract][Full Text] [Related]
2. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
3. CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation.
Gai D; Chen JR; Stewart JP; Nookaew I; Habelhah H; Ashby C; Sun F; Cheng Y; Li C; Xu H; Peng B; Garg TK; Schinke C; Thanendrarajan S; Zangari M; Chen F; Barlogie B; van Rhee F; Tricot G; Shaughnessy JD; Zhan F
J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35881476
[TBL] [Abstract][Full Text] [Related]
4. Low-Magnitude Mechanical Signals Combined with Zoledronic Acid Reduce Musculoskeletal Weakness and Adiposity in Estrogen-Deprived Mice.
Pagnotti GM; Trivedi T; Wright LE; John SK; Murthy S; Pattyn RR; Willis MS; She Y; Suresh S; Thompson WR; Rubin CT; Mohammad KS; Guise TA
bioRxiv; 2023 Mar; ():. PubMed ID: 36993656
[TBL] [Abstract][Full Text] [Related]
5. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
Li GW; Xu Z; Chang SX; Zhou L; Wang XY; Nian H; Shi X
Endocrinology; 2014 Dec; 155(12):4731-8. PubMed ID: 25243855
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state.
Lane NE; Yao W; Nakamura MC; Humphrey MB; Kimmel D; Huang X; Sheppard D; Ross FP; Teitelbaum SL
J Bone Miner Res; 2005 Jan; 20(1):58-66. PubMed ID: 15619670
[TBL] [Abstract][Full Text] [Related]
7. Anti-perimenopausal osteoporosis effects of Erzhi formula via regulation of bone resorption through osteoclast differentiation: A network pharmacology-integrated experimental study.
Qin XY; Niu ZC; Han XL; Yang Y; Wei Q; Gao XX; An R; Han LF; Yang WZ; Chai LJ; Liu EW; Gao XM; Mao HP
J Ethnopharmacol; 2021 Apr; 270():113815. PubMed ID: 33444724
[TBL] [Abstract][Full Text] [Related]
8. Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis.
Liu Z; Liang W; Kang D; Chen Q; Ouyang Z; Yan H; Huang B; Jin D; Chen Y; Li Q
Clin Interv Aging; 2020; 15():1201-1212. PubMed ID: 32764906
[TBL] [Abstract][Full Text] [Related]
9. BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.
Sun F; Cheng Y; Chen JR; Wanchai V; Mery DE; Xu H; Gai D; Al Hadidi S; Schinke C; Thanendrarajan S; Zangari M; van Rhee F; Tricot G; Shaughnessy JD; Zhan F
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37883186
[TBL] [Abstract][Full Text] [Related]
10. The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages.
Henning P; Westerlund A; Movérare-Skrtic S; Lindholm C; Márquez-Méndez M; Nilsson S; Holmberg AR; Lerner UH
Invest New Drugs; 2024 Apr; 42(2):207-220. PubMed ID: 38427117
[TBL] [Abstract][Full Text] [Related]
11. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
[TBL] [Abstract][Full Text] [Related]
13. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.
Kodama I; Niida S; Sanada M; Yoshiko Y; Tsuda M; Maeda N; Ohama K
J Bone Miner Res; 2004 Feb; 19(2):200-6. PubMed ID: 14969389
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss.
Ma L; Zhang L; Liao Z; Xiu C; Luo X; Luo N; Zhang L; He G; Chen J
J Orthop Translat; 2023 Sep; 42():1-14. PubMed ID: 37521493
[TBL] [Abstract][Full Text] [Related]
15. Dual modulation of bone formation and resorption with zoledronic acid-loaded biodegradable magnesium alloy implants improves osteoporotic fracture healing: An in vitro and in vivo study.
Li G; Zhang L; Wang L; Yuan G; Dai K; Pei J; Hao Y
Acta Biomater; 2018 Jan; 65():486-500. PubMed ID: 29079514
[TBL] [Abstract][Full Text] [Related]
16. (S)-Equol Is More Effective than (R)-Equol in Inhibiting Osteoclast Formation and Enhancing Osteoclast Apoptosis, and Reduces Estrogen Deficiency-Induced Bone Loss in Mice.
Tanaka M; Fujii S; Inoue H; Takahashi N; Ishimi Y; Uehara M
J Nutr; 2022 Aug; 152(8):1831-1842. PubMed ID: 35675296
[TBL] [Abstract][Full Text] [Related]
17. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
[TBL] [Abstract][Full Text] [Related]
19. Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice.
Zhou S; Zilberman Y; Wassermann K; Bain SD; Sadovsky Y; Gazit D
J Cell Biochem Suppl; 2001; Suppl 36():144-55. PubMed ID: 11455579
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.
Shibata T; Shira-Ishi A; Sato T; Masaki T; Masuda A; Hishiya A; Ishikura N; Higashi S; Uchida Y; Saito MO; Ito M; Ogata E; Watanabe K; Ikeda K
J Bone Miner Res; 2002 Apr; 17(4):622-9. PubMed ID: 11918219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
